Regenxbio (RGNX) Interest & Investment Income (2015 - 2025)
Regenxbio's (RGNX) quarterly Interest & Investment Income came in at -$35000.0 in Q4 2025, up 99.37% year-on-year from -$17555.6 in Q4 2024, and down 135.71% quarter-over-quarter from $98000.0 in Q3 2025.
Regenxbio (RGNX) Interest & Investment Income (2015 - 2025) Analysis & Trends
Regenxbio's Interest & Investment Income history runs 11 years deep, the most recent figure standing at -$35000.0 for Q4 2025.
- On a quarterly basis, Interest & Investment Income rose 99.37% year-over-year to -$35000.0 in Q4 2025; TTM through Dec 2025 was $3.4 million, a 7.24% decrease from a year earlier, with the FY2025 full-year figure at $54000.0, down 98.54% from the prior year.
- Interest & Investment Income eased to -$35000.0 in Q4 2025 per RGNX's latest filing, from $98000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $7.8 million in Q4 2021 and bottomed at -$9.4 million in Q1 2022.
- The 5-year median for Interest & Investment Income is $1.8 million (2022), against an average of $807950.0.
- Biggest YoY gain for Interest & Investment Income was 5090.0% in 2022; the steepest drop was 830.65% in 2022.
- Year by year, Interest & Investment Income stood at $7.8 million in 2021, then tumbled by 73.86% to $2.0 million in 2022, then decreased by 0.35% to $2.0 million in 2023, then tumbled by 373.65% to -$5.5 million in 2024, then soared by 99.37% to -$35000.0 in 2025.
- Per Business Quant, the three latest RGNX Interest & Investment Income figures stand at -$35000.0 (Q4 2025), $98000.0 (Q3 2025), and $3.4 million (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Regenxbio | 501.81 Mn | 271.74 Mn | 21.22 Mn | -35,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -35,000.00 |
| Sep 30, 2025 | 98,000.00 |
| Jun 30, 2025 | 3.38 Mn |
| Mar 31, 2025 | -21,000.00 |
| Dec 31, 2024 | -5.53 Mn |
| Sep 30, 2024 | 3.28 Mn |
| Jun 30, 2024 | 3.47 Mn |
| Mar 31, 2024 | 2.47 Mn |
| Dec 31, 2023 | 2.02 Mn |
| Sep 30, 2023 | 2.69 Mn |
| Jun 30, 2023 | 2.13 Mn |
| Mar 31, 2023 | 3.78 Mn |
| Dec 31, 2022 | 2.03 Mn |
| Sep 30, 2022 | 1.50 Mn |
| Jun 30, 2022 | -2.81 Mn |
| Mar 31, 2022 | -9.38 Mn |
| Dec 31, 2021 | 7.75 Mn |
| Sep 30, 2021 | -30,000.00 |
| Jun 30, 2021 | 399,000.00 |
| Mar 31, 2021 | -1.01 Mn |